alacort
(Hydrocortisone)Crown Laboratories
Usage: Topical corticosteroids are indicated for relief of inflammation and itching associated with corticosteroid-responsive skin disorders.
103 results
alkindi
(Hydrocortisone)Eton Pharmaceuticals, Inc.Usage: ALKINDI SPRINKLE is indicated for replacement therapy in pediatric patients suffering from adrenocortical insufficiency.amcinonide
(amcinonide)Solubiomix, LLCUsage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.analpram hc
(hydrocortisone acetate and pramoxine hydrochloride)Sebela Pharmaceuticals Inc.Usage: Topical corticosteroids are used to relieve inflammation and itching associated with skin conditions that respond to corticosteroids.arnuity ellipta
(fluticasone furoate)GlaxoSmithKline LLCUsage: ARNUITY ELLIPTA is indicated for the maintenance treatment of asthma in adults and children aged 5 years and older, but is not intended for the relief of acute bronchospasm.asmanex hfa
(MOMETASONE FUROATE)Organon LLCUsage: ASMANEX® HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 5 years and older. It is not intended for relief of acute bronchospasm.betamethasone dipropionate
(Betamethasone Dipropionate)Actavis Pharma, Inc.Usage: Betamethasone dipropionate cream is indicated for treating inflammatory and itchy skin conditions responsive to corticosteroids in patients aged 13 years and older.betamethasone dipropionate
(Betamethasone dipropionate)Lupin Pharmaceuticals, Inc.Usage: Betamethasone dipropionate ointment USP (augmented) is a corticosteroid indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions in individuals aged 13 and older.betamethasone dipropionate usp, 0.05%
(Betamethasone Dipropionate USP, 0.05%)TruPharma LLCUsage: Topical corticosteroids are indicated for relieving inflammation and itching associated with corticosteroid-responsive skin conditions.breo ellipta
(fluticasone furoate and vilanterol trifenatate)GlaxoSmithKline LLCUsage: BREO ELLIPTA is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma in patients aged 5 years and older. It is not to be used for the relief of acute bronchospasm.